Imaging/Diagnostics News

A portable handheld adaptive optics scanning laser ophthalmoscope enables cellular level imaging near the fovea of the retina, according to researchers who engineered and tested the device in a human trial.

The dry eye market has a proliferation of diagnostic and therapeutic devices that are enabling ophthalmologists to diagnose dry eye disease earlier and provide more therapeutic options.

VANCOUVER, British Columbia — The early morning religious ritual of sun gazing may be causing patients in India to experience chronic solar retinopathy with macular changes and a decrease in visual acuity, according to a speaker here.

Optovue has received 510(k) clearances from the FDA for its AngioAnalytics OCT angiography blood vessel measurement technology and for its 3-D projection artifact removal software, as well as expanded clearance for noncontact, quantitative measurements of the epithelial and stromal layers of the cornea, or epithelial thickness mapping, according to press releases.

Optos plc, part of Nikon Corp., announced the U.S. launch of Monaco, the first ultra-widefield imaging device combined with optical coherence tomography.

Wide-angle fundus digital imaging may be more effective than red reflex exam in detecting potentially visually threatening posterior segment pathology in newborns, according to a study.

According to 3-year results of the DISCOVER study, microscope-integrated intraoperative OCT during ophthalmic surgery is feasible and useful as it relates to surgical decision-making.

A pivotal FDA trial of an artificial intelligence-based system for the autonomous detection of diabetic retinopathy has met its endpoints, according to a press release from IDx.

SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Kfir Azoulay, vice president and head of corporate strategy at Heidelberg Engineering, discusses the Spectralis imaging platform.

WAILEA, Hawaii — At Hawaiian Eye 2018, David Huang, MD, PhD, discusses a longitudinal study conducted at three centers with follow-up every 6 months over 4 years using advanced diagnostics to predict glaucoma progression.